Patents by Inventor Jeffrey A. Ross

Jeffrey A. Ross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160044916
    Abstract: A method is provided for measuring the interaction of a disinfecting composition with a floor wax. The method include coating a surface with floor wax, allowing the coating to dry, applying a selected amount of disinfecting composition to the coated surface, and measuring, after a pre-determined amount of time, the tack of the surface, by using a controlled force measurement inverted probe machine. A detectable amount of tack indicates that the disinfecting composition has interacted with the floor wax. Alternatively, any tacky residue on the dried product surface may be sampled and analyzed by Fourier transform spectroscopy. Absorption at a wavelength associated with the floor wax indicates that the product has interacted with the floor wax. A foamable disinfecting composition having reduced interaction with floor wax is also provided.
    Type: Application
    Filed: October 29, 2015
    Publication date: February 18, 2016
    Inventors: Amanda Jo Copeland, Jeffrey Ross Davidson
  • Publication number: 20160030638
    Abstract: The invention provides a method for preparing a perfusion based islet cell containing extracellular matrix of liver, an islet cell recellularized extracellular matrix, and methods of using the recellularized matrix.
    Type: Application
    Filed: March 13, 2014
    Publication date: February 4, 2016
    Inventor: Jeffrey Ross
  • Publication number: 20160030637
    Abstract: The invention provides a method for maintaining capillary lumen diameter, reducing a decrease in capillary vessel lumen diameter or expanding capillary vessel lumen diameter in a re-endothelialized decellularized organ or tissue graft with an intact extracellular matrix vascular network. The method is based on administration of endothelial cells and microparticles to the decellularized ECM.
    Type: Application
    Filed: March 13, 2014
    Publication date: February 4, 2016
    Inventors: Jeffrey Ross, Dominique Seetapun
  • Patent number: 9212987
    Abstract: A method is provided for measuring the interaction of a disinfecting composition with a floor wax. The method include coating a surface with floor wax, allowing the coating to dry, applying a selected amount of disinfecting composition to the coated surface, and measuring, after a pre-determined amount of time, the tack of the surface, by using a controlled force measurement inverted probe machine. A detectable amount of tack indicates that the disinfecting composition has interacted with the floor wax. Alternatively, any tacky residue on the dried product surface may be sampled and analyzed by Fourier transform spectroscopy. Absorption at a wavelength associated with the floor wax indicates that the product has interacted with the floor wax. A foamable disinfecting composition having reduced interaction with floor wax is also provided.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: December 15, 2015
    Assignee: GOJO INDUSTRIES, INC.
    Inventors: Amanda Jo Copeland, Jeffrey Ross Davidson
  • Patent number: 9031792
    Abstract: A system and device are provided which include a gene regulatory system controlling expression of one or more expression cassettes present in or released by the device, by emitting one or more stimulations. An expression cassette includes a regulatable transcription control element that is responsive to the emitted stimulations linked to an open reading frame of interest. The system optionally includes a sensor to sense a parameter indicative of a need, a telemetry module to receive an external command, or a programmable device, for regulating gene expression of the open reading frame.
    Type: Grant
    Filed: March 27, 2006
    Date of Patent: May 12, 2015
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Darrell O. Wagner, Haris J. Sih, Jihong Qu, Jeffrey Ross, Steven D. Girouard, Ronald W. Heil, Jr.
  • Publication number: 20150018747
    Abstract: Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle using a combination of therapies. The method may include the introduction of structurally reinforcing agents. In other embodiments, agents may be introduced into a ventricle to increase compliance of the ventricle. The prevention of remodeling may include the prevention of thinning of the ventricular infarct zone. Another embodiment includes the reversing or prevention of ventricular remodeling with electro-stimulatory therapy. The unloading of the stressed myocardium over time effects reversal of undesirable ventricular remodeling. These therapies may be combined with structurally reinforcing therapies. In other embodiments, the structurally reinforcing component may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.
    Type: Application
    Filed: June 20, 2014
    Publication date: January 15, 2015
    Inventors: Eugene T. Michal, Jeffrey Ross
  • Publication number: 20140299674
    Abstract: A semiconductor device is provided which functions as a synthetic jet ejector. The semiconductor device (201) includes a first layer (203), a third layer (207), and a second layer (205) disposed between the first layer and the third layer, wherein the second layer includes a MEMS comb drive (221). The device has a plurality of apertures therein (209, 211, 213, 215 and 217) which are in fluidic communication with the comb drive and which are also in fluidic communication with the external environment. The comb drive operates to generate a plurality of synthetic jets at the plurality of apertures.
    Type: Application
    Filed: March 7, 2014
    Publication date: October 9, 2014
    Applicant: NUVENTIX, INC.
    Inventor: Jeffrey Ross Uibel
  • Publication number: 20140272106
    Abstract: A method is provided for measuring the interaction of a disinfecting composition with a floor wax. The method include coating a surface with floor wax, allowing the coating to dry, applying a selected amount of disinfecting composition to the coated surface, and measuring, after a pre-determined amount of time, the tack of the surface, by using a controlled force measurement inverted probe machine. A detectable amount of tack indicates that the disinfecting composition has interacted with the floor wax. Alternatively, any tacky residue on the dried product surface may be sampled and analyzed by Fourier transform spectroscopy. Absorption at a wavelength associated with the floor wax indicates that the product has interacted with the floor wax. A foamable disinfecting composition having reduced interaction with floor wax is also provided.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: GOJO INDUSTRIES, INC.
    Inventors: Amanda Jo Copeland, Jeffrey Ross Davidson
  • Patent number: 8795652
    Abstract: Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle using a combination of therapies. The method may include the introduction of structurally reinforcing agents. In other embodiments, agents may be introduced into a ventricle to increase compliance of the ventricle. The prevention of remodeling may include the prevention of thinning of the ventricular infarct zone. Another embodiment includes the reversing or prevention of ventricular remodeling with electro-stimulatory therapy. The unloading of the stressed myocardium over time effects reversal of undesirable ventricular remodeling. These therapies may be combined with structurally reinforcing therapies. In other embodiments, the structurally reinforcing component may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.
    Type: Grant
    Filed: November 12, 2007
    Date of Patent: August 5, 2014
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Eugene T. Michal, Jeffrey Ross
  • Patent number: 8731677
    Abstract: Various system embodiments comprise a neural stimulator, a pulse generator, and a controller. The neural stimulator is adapted to generate a neural stimulation signal. The pulse generator is adapted to generate a pacing signal to provide myocardium pacing. The controller is adapted to control the neural stimulator and the pulse generator to provide a cardioprotective conditioning therapy. The conditioning therapy includes neural stimulation to elicit a parasympathetic response and myocardium pacing. Other aspects and embodiments are provided herein.
    Type: Grant
    Filed: February 10, 2010
    Date of Patent: May 20, 2014
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Joseph M. Pastore, Tamara Colette Baynham, Andrew P. Kramer, Julio C. Spinelli, Jeffrey Ross, Rodney W. Salo
  • Patent number: 8696564
    Abstract: All or a portion of a surface of an implantable sensor is covered with a biocompatible coating formed at least partially of a biomaterial matrix having properties that promote a substantially even growth of tissue cells over the surface of the coating. Additional materials, such as growth factors, agents that recruit endogenous stem cells, and cell adhesion motif arginine, glycine, aspartic acid may be included in the coating. Autologous cells may be added to the coating prior to implantation. The sensor surface may also be textured, by etching or abrading, in order to promote even tissue growth. Alternatively, the sensor surface may be covered with a coating having properties that inhibit the growth of tissue. These coatings may include a biomaterial, a biomaterial matrix having a drug, such as a sirolimus or a steroid, an active component, or a self assembled monolayer.
    Type: Grant
    Filed: July 9, 2004
    Date of Patent: April 15, 2014
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Abhi Chavan, Jeffrey Ross, Cynthia Morrissey, Scott Mazar, Donald Palme
  • Publication number: 20130337560
    Abstract: The invention provides methods for decellularizing bone, e.g., human bone.
    Type: Application
    Filed: March 6, 2013
    Publication date: December 19, 2013
    Applicant: Miromatrix Medical Inc.
    Inventors: Jeffrey Ross, Blaise Porter
  • Patent number: 8538520
    Abstract: A gene regulatory system detects ischemia events and is capable of delivering a biologic therapy in response to the detection of an ischemic event or the reception of a command. The biologic therapy protects the heart from ischemic damage by regulating the expression of an exogenously introduced gene product. In one embodiment, the gene regulatory system includes an implantable system that emits at least one gene regulatory signal in response to the detection of the ischemic event or the reception of the command. The gene regulatory signal directly or indirectly regulates gene expression of the gene product.
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: September 17, 2013
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Joseph M. Pastore, Jeffrey Ross, Tamara Colette Baynham, Rodney W. Salo, Andrew P. Kramer, Julio C. Spinelli
  • Patent number: 8526518
    Abstract: Most modern integrated circuit transceivers, especially wireless LAN, utilize a direct conversion radio architecture, which is highly advantageous from the perspectives of cost and flexibility, there exist several performance impairments, including gain and phase imbalances between the in-phase (I) and quadrature (Q) of a transmitter or receiver. Disclosed herein is a signal processing methodology and system for compensation of I/Q imbalance for a direct conversion packet-switched OFDM communications system. The imbalance, which accounts for transmitter I/Q imbalance, RX I/Q imbalance, phase/frequency error, and dispersive multipath fading. Both frequency dependent I/Q imbalance and frequency independent cases are considered, covering both wideband and narrowband modulation. The proposed estimation algorithms operate within the fully compliant framework of existing multi-user OFDM radio standards (WLAN, LTE, WimAX).
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: September 3, 2013
    Assignee: Skyworks Solutions, Inc.
    Inventors: Jeffrey Ross Feigin, David Paul Brady
  • Patent number: 8346356
    Abstract: An implantable system which includes a gene/protein delivery device and a pulse generator, as well as method of preparing the gene/protein delivery device and using the system, are provided. In one embodiment, the implantable system detects a predetermined condition or event and, in response, delivers gene(s) and/or protein(s) in conjunction with delivering pacing and/or defibrillation pulses.
    Type: Grant
    Filed: March 25, 2010
    Date of Patent: January 1, 2013
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Steven D. Girouard, Jeffrey Ross
  • Patent number: 8192348
    Abstract: The present invention relates to engineered blood vessels and methods of making such vessels using matrices comprising endothelial and smooth muscle cells, or cells capable of differentiating into endothelial and smooth muscle cell lineages (e.g., stem cells, or the progenitors thereof).
    Type: Grant
    Filed: July 1, 2004
    Date of Patent: June 5, 2012
    Assignee: Regents of the University of Minnesota
    Inventors: Robert T. Tranquillo, Jeffrey Ross, Morayma Reyes
  • Publication number: 20120064537
    Abstract: The invention provides a method for preparing a perfusion based 3D cell culture system, a recellularized matrix culture system, and methods of using the culture system.
    Type: Application
    Filed: June 30, 2011
    Publication date: March 15, 2012
    Applicant: Miromatrix Medical Inc.
    Inventor: Jeffrey Ross
  • Patent number: 8121684
    Abstract: A cardiac rhythm management device is configured to deliver pre-excitation pacing to one or more sites in proximity to an infarcted region of the ventricular myocardium. The pre-excitation pacing in conjunction with counterpulsation therapy serves to either prevent or minimize post-infarct remodeling.
    Type: Grant
    Filed: November 10, 2008
    Date of Patent: February 21, 2012
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Jeffrey Ross, Julio C. Spinelli, Rodney W. Salo
  • Patent number: 8060219
    Abstract: An epicardial patch includes an extracellular matrix (ECM) and a plurality of electrodes. The isolated ECM is configured for epicardial attachment over a myocardial region including an injured area to control post-injury remodeling of the myocardial region. The plurality of electrodes is configured for delivering electrical stimulation to enhance the effect of the isolated ECM in remodeling control by altering workload and stress on the myocardial region.
    Type: Grant
    Filed: December 20, 2004
    Date of Patent: November 15, 2011
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Jeffrey Ross, John Kim, Rodney W. Salo, Ronald W. Heil, Jr., Randy Westlund
  • Publication number: 20110258661
    Abstract: An interactive television program guide system and method is provided. Time separators are displayed within lists of program listings to allow users to more easily view the program listings. On-screen arrows have their display characteristics changed according to user actions. Similar program listings are displayed only once when using search program listings. Users are provided with an opportunity to view channel information before setting channels as favorites. Information from local information services is provided in program guide display screens that are configurable by a main facility. Users are provided with an opportunity to centrally lock and unlock programs, and to bypass locks when desired.
    Type: Application
    Filed: June 30, 2011
    Publication date: October 20, 2011
    Applicant: Rovi Technologies Corporation
    Inventors: Edward B. Knudson, Michael D. Ellis, W. Benjamin Herrington, Steven C. Williamson, Pamela L. McKissick, William L. Thomas, David M. Berezowski, Kenneth F. Carpenter, JR., Jeffrey A. Ross, Daniel C. Hagenbuch, Steven J. Reynolds, David M. Rudnick